盐酸右美托咪定经口用药临床效果观察-前瞻性随机对照研究

中华养生保健 ›› 2023, Vol. 41 ›› Issue (9): 26-29.

盐酸右美托咪定经口用药临床效果观察-前瞻性随机对照研究

李牧¹, 杨森^2,*

1.锦州医科大学锦州市中心医院研究生培养基地,辽宁锦州,121000;
2.锦州市中心医院麻醉科,辽宁锦州,121000

出版日期:2023-05-01 发布日期:2023-04-23
通讯作者: ^*杨森,E-mail：414251682@qq.com。
作者简介:李牧（1997—）,男,汉族,籍贯：北京市,硕士研究生在读,研究方向：围术期心肌保护。

Observation of Clinical Effect of Oral Administration of Dexmedetomidine Hydrochloride-a Prospective Randomized Controlled Study

LI Mu¹, YANG Sen²

1. Graduate Training Base, Jinzhou Central Hospital, Jinzhou Medical University, Jinzhou Liaoning 121000, China;
2. Department of Anesthesiology, Jinzhou Central Hospital, Jinzhou Liaoning 121000, China

Online:2023-05-01 Published:2023-04-23

摘要/Abstract

摘要： 目的观察盐酸右美托咪定经口给药对椎管内麻醉患者的镇静效果。方法选择锦州市中心医院拟行硬脊联合麻醉患者[美国麻醉师协会（ASA）分级Ⅱ级]60例,采用随机数表法将患者均分为对照组（A组）、右美托咪定雾化吸入组（B组）及右美托咪定口腔喷雾组（C组）,每组20例。记录三组患者入室（T0）、麻醉后（T1）给予右美托咪定后10 min（T2）、20 min（T3）及30 min（T4）的镇静评分及心率变化,同时记录硬脊联合麻醉患者给药后的入睡时间,记录各组患者心动过缓、低血压等不良反应发生率。结果 A组与B组患者在各时间点的心率及镇静评分比较,差异无统计学意义（P>0.05）;与A、B两组比较,C组患者在T3时刻心率出现明显降低,镇静评分增加（P<0.05）;C组T3与T0、T1时刻比较,心率降低,镇静评分增高,差异有统计学意义（P<0.05）,与T4时刻心率及镇静评分比较,差异无统计学意义（P>0.05）。其中,C组患者在给药后可进入睡眠状态,入睡时间为给药后（60.15±7.66）min。三组患者中仅C组出现2例短时间呛咳,其余患者均未观察到不良反应。结论盐酸右美托咪定1.5 μg/kg经口腔颊黏膜喷雾的给药方式可取得较好的镇静效果。

关键词: 盐酸右美托咪定, 镇静评分, 经口给药

Abstract: Objective To observe the sedative effect of dexmedetomidine hydrochloride on patients under spinal anesthesia. Methods A total of 60 patients [The American Society of Anesthesiologists (ASA) is graded II] were selected from Jinzhou Central Hospital. Using random number table method, the patients were divided into 3 groups (n=20): control group (group A), dexmedetomidine atomization inhalation group (group B) and dexmedetomidine oral spray group (C group). The sedation scores and heart rate changes of patients entering the room (T0) and after anesthesia (T1) after dexmedetomidine administration were recorded at 10 minutes (T2), 20 minutes (T3) and 30 minutes (T4), and the time to sleep after administration in patients with scleropractic combined anesthesia is recorded. The incidence of adverse reactions such as bradycardia and hypotension in each group were recorded. Results Compared with group A, there was no significant difference in the changes of heart rate and sedation score in group B at each time point (P>0.05). with T0 and T1 in group C, the heart rate decreased and the sedation score increased, with a statistically significant difference (P<0.05), but there was no significant difference compared with T4 (P>0.05). Among them, patients in group C could enter sleep state after administration, and the time to fall asleep was (60.15±7.66) min after administration. Among the three groups of patients, only 2 cases of short-term choking occurred in group C, and no adverse reactions were observed in other patients. Conclusion Compared with the control group, there was no significant change in the administration mode of dexmedetomidine hydrochloride 1.5 μg/kg through oral atomization. The administration mode of dexmedetomidine hydrochloride through buccal mucosa spray could produce better sedative effect.

Key words: dexmedetomidine hydrochloride, sedation score, oral administration

中图分类号:

R614.4

李牧, 杨森. 盐酸右美托咪定经口用药临床效果观察-前瞻性随机对照研究[J]. 中华养生保健, 2023, 41(9): 26-29.

LI Mu, YANG Sen. Observation of Clinical Effect of Oral Administration of Dexmedetomidine Hydrochloride-a Prospective Randomized Controlled Study[J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(9): 26-29.

参考文献

[1] 钱秋,李月琴.右美托咪定滴鼻预防儿童七氟烷全麻苏醒期躁动的有效性分析[J].沈阳药科大学学报,2021,38(S1):54.
[2] 熊依铭,胡华胜,金牮.盐酸右美托咪定舌下片的制备及体内外评价[J].药物评价研究,2022,45(4):719-725.
[3] RABI ANDALOUSSI M.Nebulized dexmedetomidine as a rescue agent for an emergent awake tracheostomy: A case report[J]. J Clin Anesth,2021,75:110465.
[4] ANTTILA M, PENTTILA J, HELMINEN A, et al.Bioavailability of dexmedetomidine after extravascular doses in healthy subjects[J]. Br J Clin Pharmacol,2003,56:691-693.
[5] RASHEED A M, AMIRAH M F, ABDALLAH M, et al.Ramsay Sedation Scale and Richmond Agitation Sedation Scale:A Cross-sectional Study[J].Dimens Crit Care Nurs,2019,38(2):90-95.
[6] KUROSU A, COYLE J L, DUDIK J M, et al.Detection of swallow kinematic events from acoustic high-resolution cervical auscultation signals in patients with stroke[J]. Arch Phys Med Rehabil,2019,100(3):501-508.
[7] STAMENKOVIC D M, RANCIC N K, LATAS M B, et al.Preoperative anxiety and implications on postoperative recovery:what can we do to change our history[J]. Minerva Anestesiol,2018,84(11):1307-1317.
[8] DOAN L V, BLITZ J.Preoperative Assessment and Management of Patients with Pain and Anxiety Disorders[J]. Curr Anesthesiol Rep,2020,10(1):28-34.
[9] IMPELLIZZERI P, VINCI E, GUGLIANDOLO M C, et al.Premedication with melatonin vs midazolam:efficacy on anxiety and compliance in paediatric surgical patients[J]. Eur J Pediatr,2017,176(7):947-953.
[10] 姜雪莺,李天佐,李丽.术前口服咪达唑仑用于小儿七氟烷麻醉的临床观察[J]. 中华医学杂志,2010,90(37):2633-2635.
[11] LANE R D, SCHUNK J E.Atomized intranasal midazolam use for minor procedures in the pediatric emergency department[J]. Pediatr Emerg Care,2008,24(5):300-303.
[12] MIHALJEVI S, PAVLOVI M, REINER K, et al.Therapeutic Mechanisms of Ketamine[J]. Psychiatr Danub,2020,32(3-4):325-333.
[13] GUTHRIE D B, BOORIN M R, SISTI A R, et al.Retrospective Comparison of Intramuscular Admixtures of Ketamine and Dexmedetomidine Versus Ketamine and Midazolam for Preoperative Sedation[J]. Anesth Prog,2021,68(1):3-9.
[14] LIU X, LI Y, KANG L, et al.Recent Advances in the Clinical Value and Potential of Dexmedetomidine[J]. J Inflamm Res,2021,14:7507-7527.
[15] LEE S.Dexmedetomidine:present and future directions[J]. Korean J Anesthesiol,2019,72(4):323-330.
[16] 黄晶,巨修练,吴有斌.右美托咪定新型给药系统的临床研究进展[J].山东化工,2020,49(5):99-101.
[17] 李晓芳,李军,田建民,等.右美托咪定滴鼻对老年患者全麻苏醒质量的影响[J].中国合理用药探索,2021,18(7):78-82.
[18] 郭号,牛飞梦,许银实.右美托咪定滴鼻用于小儿术前镇静效果的Meta分析[J].中国妇幼保健,2022,37(10):1932-1938.